Ocular Therapeutix Inc (OCUL)
5.75
+0.71
(+14.09%)
USD |
NASDAQ |
Jun 14, 16:00
5.84
+0.09
(+1.57%)
After-Hours: 20:00
Ocular Therapeutix Gross Profit (Quarterly): 13.45M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 13.45M |
December 31, 2023 | 13.42M |
September 30, 2023 | 13.70M |
June 30, 2023 | 13.88M |
March 31, 2023 | 12.16M |
December 31, 2022 | 13.06M |
September 30, 2022 | 10.89M |
June 30, 2022 | 11.11M |
March 31, 2022 | 11.89M |
December 31, 2021 | 11.20M |
September 30, 2021 | 10.84M |
June 30, 2021 | 10.62M |
March 31, 2021 | 6.45M |
December 31, 2020 | 6.669M |
September 30, 2020 | 5.426M |
June 30, 2020 | 1.435M |
March 31, 2020 | 1.79M |
December 31, 2019 | 1.417M |
September 30, 2019 | 0.023M |
June 30, 2019 | 0.098M |
March 31, 2019 | 0.364M |
Date | Value |
---|---|
December 31, 2018 | 0.387M |
September 30, 2018 | 0.383M |
June 30, 2018 | 0.495M |
March 31, 2018 | 0.26M |
December 31, 2017 | 0.374M |
September 30, 2017 | 0.398M |
June 30, 2017 | 0.334M |
March 31, 2017 | 0.36M |
December 31, 2016 | 0.384M |
September 30, 2016 | 0.365M |
June 30, 2016 | 0.336M |
March 31, 2016 | 0.359M |
December 31, 2015 | 0.344M |
September 30, 2015 | 0.338M |
June 30, 2015 | 0.379M |
March 31, 2015 | 0.37M |
December 31, 2014 | 0.475M |
September 30, 2014 | 0.111M |
June 30, 2014 | 0.077M |
March 31, 2014 | 0.018M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
0.023M
Minimum
Sep 2019
13.88M
Maximum
Jun 2023
8.477M
Average
10.87M
Median
Gross Profit (Quarterly) Benchmarks
Amgen Inc | 4.247B |
EyePoint Pharmaceuticals Inc | 10.92M |
Regeneron Pharmaceuticals Inc | 2.711B |
Agios Pharmaceuticals Inc | 7.562M |
Fate Therapeutics Inc | -- |